These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8218842)

  • 21. CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice.
    Akhtar I; Gold JP; Pan LY; Ferrara JL; Yang XD; Kim JI; Tan KN
    J Exp Med; 1995 Jul; 182(1):87-97. PubMed ID: 7790825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of CD4+CD45RA+ T cells in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse.
    Sempé P; Ezine S; Marvel J; Bédossa P; Richard MF; Bach JF; Boitard C
    Int Immunol; 1993 May; 5(5):479-89. PubMed ID: 8318452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-10 diminishes CTLA-4 expression on islet-resident T cells and sustains their activation rather than tolerance.
    Gregg RK; Bell JJ; Lee HH; Jain R; Schoenleber SJ; Divekar R; Zaghouani H
    J Immunol; 2005 Jan; 174(2):662-70. PubMed ID: 15634884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-selectin is not required for T cell-mediated autoimmune diabetes.
    Friedline RH; Wong CP; Steeber DA; Tedder TF; Tisch R
    J Immunol; 2002 Mar; 168(6):2659-66. PubMed ID: 11884430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The contribution of animal models to the understanding of the pathogenesis of type 1 diabetes.
    Carnaud C
    Braz J Med Biol Res; 1995 Aug; 28(8):925-9. PubMed ID: 8555997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand-dependent induction of noninflammatory dendritic cells by anergic invariant NKT cells minimizes autoimmune inflammation.
    Wang J; Cho S; Ueno A; Cheng L; Xu BY; Desrosiers MD; Shi Y; Yang Y
    J Immunol; 2008 Aug; 181(4):2438-45. PubMed ID: 18684934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes.
    Trembleau S; Penna G; Gregori S; Gately MK; Adorini L
    Eur J Immunol; 1997 Sep; 27(9):2330-9. PubMed ID: 9341777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
    Hussain S; Delovitch TL
    J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Islet xenografting in autoimmune diabetes.
    Gill RG; Coulombe M
    Transplant Proc; 1994 Jun; 26(3):1140. PubMed ID: 7913256
    [No Abstract]   [Full Text] [Related]  

  • 31. Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; nonimmunized nonobese diabetic mice can develop autoimmune encephalitis.
    Winer S; Astsaturov I; Cheung R; Gunaratnam L; Kubiak V; Cortez MA; Moscarello M; O'Connor PW; McKerlie C; Becker DJ; Dosch HM
    J Immunol; 2001 Feb; 166(4):2831-41. PubMed ID: 11160351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes.
    Horwitz MS; Ilic A; Fine C; Rodriguez E; Sarvetnick N
    J Clin Invest; 2002 Jan; 109(1):79-87. PubMed ID: 11781353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigen-presenting cells in adoptively transferred and spontaneous autoimmune diabetes.
    Lo D; Reilly CR; Scott B; Liblau R; McDevitt HO; Burkly LC
    Eur J Immunol; 1993 Jul; 23(7):1693-8. PubMed ID: 7686860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A defect in central tolerance in NOD mice.
    Kishimoto H; Sprent J
    Nat Immunol; 2001 Nov; 2(11):1025-31. PubMed ID: 11668341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice.
    Saï P; Senecat O; Martignat L; Gouin E
    Clin Exp Immunol; 1994 Jul; 97(1):138-45. PubMed ID: 8033411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic cells in the autoimmune insulitis in NOD mouse models of diabetes.
    Rosmalen JG; Leenen PJ; Katz JD; Voerman JS; Drexhage HA
    Adv Exp Med Biol; 1997; 417():291-4. PubMed ID: 9286375
    [No Abstract]   [Full Text] [Related]  

  • 37. Transplanted MHC class I-deficient nonobese diabetic mouse islets are protected from autoimmune injury in diabetic nonobese recipients.
    Prange S; Zucker P; Jevnikar AM; Singh B
    Transplantation; 2001 Apr; 71(7):982-5. PubMed ID: 11349735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent.
    Serreze DV; Chapman HD; Varnum DS; Gerling I; Leiter EH; Shultz LD
    J Immunol; 1997 Apr; 158(8):3978-86. PubMed ID: 9103469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of vasostatin-1-specific CD8(+) T cells in non-obese diabetic mice that contribute to diabetes pathogenesis.
    Nikoopour E; Krougly O; Lee-Chan E; Haeryfar SM; Singh B
    Clin Exp Immunol; 2016 Sep; 185(3):292-300. PubMed ID: 27185276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intervention therapies for insulin-dependent diabetes.
    Muir A; Schatz DA; Pozzilli P; MacLaren NK
    Autoimmunity; 1993; 16(4):301-10. PubMed ID: 8025209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.